Stocktoria
Omada Health, Inc. OMDA
Omada Health, Inc. financials (annual)
Bars are annual figures from 2024 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | $260.2M | $169.8M |
| Gross profit | $170.9M | $102.9M |
| R&D expense | $40.7M | $35.9M |
| Operating income | -$12.0M | -$43.7M |
| Income tax | $0 | $0 |
| Net income | -$12.8M | -$47.1M |
| EPS (diluted) | $-0.35 | $-6.11 |
| Operating cash flow | $18.3M | -$34.2M |
| Free cash flow | $16.9M | -$34.8M |
| Cash & equivalents | $222.0M | $76.4M |
| Inventory | $4.5M | $3.3M |
| Total assets | $305.4M | $150.9M |
| Total liabilities | $75.7M | $86.3M |
| Shareholders' equity | $229.7M | -$384.4M |
Growth · year-over-year · Revenue CAGR 53.2%
| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue growth | +53.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.